pentobarbital will reduce the level or influence of cobimetinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Prevent coadministration. Strong or moderate CYP3A inducers may possibly minimize cobimetinib systemic exposure by >eighty% and reduce its efficacy.There isn't any information on pregnancy exposures in primates